1. Home
  2. AADX vs BEAM Comparison

AADX vs BEAM Comparison

Compare AADX & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Applied Aerospace & Defense Inc. Common Stock

AADX

Applied Aerospace & Defense Inc. Common Stock

HOLD

Current Price

$9.90

Market Cap

3.3B

Sector

Industrials

ML Signal

HOLD

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

HOLD

Current Price

$24.57

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AADX
BEAM
Founded
1900
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
2.6B
IPO Year
2026
2019

Fundamental Metrics

Financial Performance
Metric
AADX
BEAM
Price
$9.90
$24.57
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
15
Target Price
$22.88
★ $52.15
AVG Volume (30 Days)
★ 1.9M
1.5M
Earning Date
11-11-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 82.31
EPS
★ N/A
N/A
Revenue
N/A
★ $24,000.00
Revenue This Year
$36.93
N/A
Revenue Next Year
$15.57
$29.19
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 33.33
52 Week Low
$10.31
$20.23
52 Week High
$24.24
$38.26

Technical Indicators

Market Signals
Indicator
AADX
BEAM
Relative Strength Index (RSI) 33.00 46.76
Support Level N/A $24.30
Resistance Level $13.03 $26.72
Average True Range (ATR) 0.75 1.30
MACD 0.01 0.09
Stochastic Oscillator 6.98 33.33

Price Performance

Historical Comparison
AADX
BEAM

About AADX Applied Aerospace & Defense Inc. Common Stock

Applied Aerospace & Defense Inc specializes in providing engineering and vertically integrated manufacturing solutions for space and defense technology companies. The company builds complex hardware for extreme operating environments, combining deep material science and IP-enabled process expertise with the ability to enable rapid prototyping, enhance new product development, and responsively scale production. The majority of the company's revenue is derived from the sales of Defense Aviation and Airborne Systems, followed by Space and Launch Systems, C5ISR and Precision Strike Systems.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.

Share on Social Networks: